HLA Antigens in Mucocutaneous Lymph Node Syndrome
- 1 December 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 131 (12), 1417-1418
- https://doi.org/10.1001/archpedi.1977.02120250099033
Abstract
Kawasaki disease or mucocutaneous lymph node syndrome (MLNS), first described by Kawasaki1-2in 1974, is an acute febrile disease of unknown etiology. Until recently, more than 6,000 cases of this disease have been listed in the survey of a special study group supported by the Japanese Ministry of Health and Welfare. Although a number of cases have been accumulated even outside of Japan,3-6 it is much less common elsewhere. The etiology of the disease is now under investigation including the isolation of aRickettsia-like body.7There is a possibility that an immunopathological mechanism similar to that of juvenile rheumatoid arthritis and infantile polyarteritis nodosa is responsible, as evidenced by cardiac involvement, increased erythrocyte sedimentation rate, positive C-reactive protein and increased α2-globulin in serum. Several immunopathological diseases are known to be associated with individual human lymphocytes antigen (HLA),8but to date no investigation has beenKeywords
This publication has 2 references indexed in Scilit:
- Mucocutaneous Lymph Node Syndrome in ArizonaArchives of Pediatrics & Adolescent Medicine, 1976
- Mucocutaneous Lymph Node Syndrome in the United StatesArchives of Pediatrics & Adolescent Medicine, 1976